BACFO Pharmaceuticals (India) Ltd. is a prominent player in the biotechnology, healthcare, and pharmaceutical industries. Established in 1994, the company has positioned itself as a leading manufacturer and exporter of nutraceutical supplements, sports nutrition, herbal medicine, and personal care products. Its state-of-the-art facility in Noida, spanning over 140,000 sq. ft., is equipped to produce a wide range of products under strict quality controls and has garnered certifications including NSF GMP, FSSC 22000, ISO 22000, and cGMP.
The company's commitment to maintaining quality is underscored by its certifications from Ecocert, Halal, and USFDA, as well as its recognition by the Department of Scientific & Industrial Research (DSIR), Government of India. Notably, BACFO has received the 'Outstanding Export Achievement Award' by Pharmexcil, Government of India, showcasing its prowess in international markets.
BACFO is backed by the global AKC Group, whose promoters have a strong track record in various sectors including plastics, pharmaceuticals, packaging, education, technology transfer, and more. The group, established in 1976, boasts a workforce of over 12,000, underlining its extensive experience and resources.
Overall, BACFO Pharmaceuticals (India) Ltd. has made significant strides in the healthcare and pharmaceutical arenas, leveraging its robust infrastructure, quality certifications, and strong backing by the AKC Group to solidify its position in the market.
There is no investment information
No recent news or press coverage available for BACFO Pharmaceuticals (India) Ltd..